Hi everyone, just curious to see where everyone stands with their position. How many shares are you currently holding, and what’s your target? I had it before and sold April 2025 for a lost.

I’m looking to add another 200 shares if the price dips below $90.

https://preview.redd.it/edg54o1h85fh1.png?width=960&format=png&auto=webp&s=486b1e6736275dd43baa7beca5b041d2cd411640

SUMMARY :

Despite the seasonally weaker quarter, it was the company's best quarter, which speaks volumes about HITI's increased operating efficiency.

Gms on medical cannabis 27%

https://preview.redd.it/2jokk3oi85fh1.png?width=1080&format=png&auto=webp&s=e304dc9cb392241d727e70cbbd3a0214e57c3fe4

https://preview.redd.it/zpo8649j85fh1.png?width=1080&format=png&auto=webp&s=8e6fa2545688874d3b47624b294e55e9141ee651

Key Strengths of High Tide's Q2 FY2026

1. Strong Revenue Growth

• Record revenue of CAD $179.3 million.
• Approximately 30% year-over-year growth, representing one of the strongest growth rates in recent quarters.

2. Accelerating EBITDA Growth

• Record Adjusted EBITDA of CAD $13.9 million.
• EBITDA increased by approximately 73% year over year, significantly outpacing revenue growth, which indicates improving operating leverage and efficiency.

3. Positive Net Income

• The company reported positive net income and positive earnings per share (EPS).
• In the cannabis industry, profitability remains a major challenge for many companies, making High Tide's continued profitability particularly noteworthy.
• Management expects sustainable NET INCOME

4. Positive Free Cash Flow

• High Tide generated positive free cash flow and strong operating cash flow.
• This reduces the need to raise capital through equity issuances, helping to limit shareholder dilution.

5. Germany Continues to Exceed Expectations

• German subsidiary Remexian Pharma GmbH generated a record CAD $31.6 million in revenue.
• Gross margin improved to 27%.
• Management stated that several internal targets were achieved roughly 90 days ahead of schedule.

6. Rapid Expansion of the Customer Base

• The Cabana Club loyalty program surpassed 2.65 million members, up 39% year over year.
• ELITE memberships exceeded 178,000, up 84% year over year.
• This growing membership ecosystem strengthens customer loyalty, improves data analytics capabilities, and enhances High Tide's competitive advantage in retail.
• The stated goal is to exceed 1 million elite members in the long term.

7. Significant Banking Support

• The company secured a new credit facility of up to CAD $40 million from Bank of Montreal.
• Access to financing from a major Canadian bank is an important signal of financial credibility and stability in the cannabis sector.
• This has led to an increase in institutional interest in the stock which will be reflected as the company's fundamentals continue to improve.

8. Market Leadership

• High Tide continues to hold approximately 12% of the Canadian cannabis retail market in the provinces where it operates.
• The company is also steadily gaining market share in the German medical cannabis market.
• Raj is targeting 20% ​​market share in Germany and I personally believe 30% is achievable in the long term for several reasons.

Most Bullish Takeaways

If I had to identify nine most bullish developments from the quarter, they would be:

1. 73% growth in Adjusted EBITDA, demonstrating strong operational execution.
2. Remexian's 27% gross margin, showing that the German business is scaling successfully and profitably.
3. The new CAD $40 million credit facility, which provides growth capital without diluting shareholders.
4. SNDL will have to sell some of its assets because it has violated regulations for years, and I wouldn't be surprised if it had to pay a hefty fine for breaking the law for so long. These assets will be carefully evaluated by Hiti for purchase.
5. Possible increase in the cap in Ontario from 150->300 which Raj calls "a dream come true" bringing the number of canna cabana shops +500, but we'll have to see how things evolve
6. The medical branch is growing throughout Europe, a constantly growing market, where Raj intends to be the leader in every country in which it operates (Germany, UK to follow).
7. GMS have reached an all-time high. Raj states that due to competition, they will shrink slightly in the medium term in order to gain market share, but thanks to initiatives such as increasing ELITE/WHITE LABEL inventory from the current 2% to 25%, GMS will exceed 30% in the long term, also driven by Remexian's improved efficiency.
8. Raj has stated his intention to enter the US, but for now he's focused on the European medical market and I support that.
9. He says there's no rush to pursue multiple objectives at once, but rather to focus on one market at a time, strengthen its position by positioning itself as a leader, and move on to the next.

Together, these results suggest that High Tide is evolving from a pure growth story into a profitable growth company, a transition that investors often reward with higher valuation multiples over time.

HITI is becoming the definition of non-stop execution and deserves more credit for this. Remexian's goal is clear: gain more market share to satisfy this insatiable and ever-growing demand, in order to reach 20-30% market share in the long term and then achieve pricing determination with a consequent increase in GMS and profitability.

Still think HITI is vastly undiscovered.

Despite an increase in CAPEX linked to the expansion, the company continues to generate FCF+ and expects to increase net income thanks to ongoing synergies.

Raj is carefully evaluating expansion into another jurisdiction (UK), choosing the right partner for the long term.

This looks more like short-term noise than a deterioration in fundamentals. Remexian’s expansion in Germany and the economies of scale enjoyed by Canna Cabana represent genuine, differentiating competitive advantages. As long as management continues to pursue its market share targets and secure future pricing power, the valuation gap should gradually narrow. Investing in HITI will certainly be volatile, but the current fundamentals are much healthier than the stock price suggests. What's needed is patience and faith in the story.

The UK is the European market that excites him the most.

The UK medical market appears more interesting than the German one because High Tide could own the entire chain (from production directly to the patient). This is the medical system in which it is structured, which makes it exciting and unique in some respects.

I might be biased because HITI is my largest position by a wide margin, but that’s not why I’m saying this. Execution here has simply been exceptional. The numbers speak for themselves, the customer wins speak for themselves, and the pace of announcements speaks for itself.

https://preview.redd.it/8s1lh6d295fh1.jpg?width=2487&format=pjpg&auto=webp&s=5676ea83608292614f8d5dc856882951b5879468

Every analyst covering the company has a Buy rating

Canaccord Genuity → Buy, Target $US 5.50

Haywood → Buy, Target $US 5.90

Roth → Buy, target $US 5.00

TD Cowen → Buy, target $6.5 CAD

ATB CAPITAL Target 7$CAD

https://preview.redd.it/ukywmk6r85fh1.png?width=1080&format=png&auto=webp&s=3d8d9c7cdcab7443eac8585cfa07087862191802

company presentation https://hightideinc.com/presentation/

I am Long term

Hi everyone,
I’m still fairly new to investing, but I finally decided to start because I find it genuinely interesting. I invested around €30,000, and my portfolio currently looks like this:
Vanguard S&P 500 (VUAA): ~37% (€11.2k)
TSMC: ~19% (€5.7k)
NVIDIA: ~16% (€4.8k)
AMD: ~13% (€3.8k)
ASML: ~9% (€2.7k)
Nebius Group: ~7% (€2.0k)
The portfolio is obviously heavily focused on AI and semiconductors. That’s intentional, because I believe AI still has a lot of long-term growth ahead.
So far, it’s worked out pretty well. I’m up around €1,300 in just two weeks. I know that’s a very short time frame and doesn’t mean much in the long run, but it got me thinking about something I don’t really know the answer to.
When do you actually take profits?
If your investment thesis is simply that AI will keep growing over the coming years, do you just keep holding until something fundamentally changes? Or do you regularly lock in gains?
For example, is it reasonable to think something like: “I believe AI will keep doing well, so I’ll probably hold until around 2028 (when Trump leaves office), unless something changes.” Or is that not how experienced investors think about it?

Please consider taking a close look to benefit everyone.

Many noises happening in the KOSPI market has almost nothing to do with SK Hynix's fundamentals yet they are the main short-term drivers of extreme volatility (e.g. US-Iran war, leverage ETF crisis, institutional portfolio rebalances).

I'm a long-term investor and focuses on fundamentals but the short-term volatility has surely brought stress. My purpose here is to invite you to challenge my valuation assumptions so we can have our own fair price per share estimate from a retail perspective.

Valuation & Triangulate Methods

1. Equal weight between one DCF bull scenario and one DCF bear scenario to reflect neutrality.
2. Multiples Methods are used to cross-check (not triangulated) DCF outputs. Bear in mind that they are vastly more backward looking in an HBM-less market and inherently means they are more bearish. Past 5Y median EV/EBITDA and P/B methods are used to better reflect a full cycle of the CAPEX-heavy cyclical sector.

Basic Assumptions of DCF & Explicit Choices

• Projected 3Y FCFF uses available analysts consensus estimate from 2026E to 2028E. Sourced from capIQ.

(Consensus blends both bearish and bullish analyst estimates, hence assumes 3Y FCFF reflects neutrality.)

• Risk-free rate uses the 10Y South Korea government bond yield.
• Equity risk premium is sourced from Damodaran Aswath Risk Premiums.
• CapIQ doesn't provide Beta figures for SK Hynix most likely because it's not a US company, hence approximated by memory sector peer average.
• Bear and Bull DCF scenarios are weighted equally to reflect neutrality.
• Terminal growth ≈ SK average inflation rate.

(This is very conservative assuming that SK Hynix perfectly matures after 2028, a good reflection of analyst consensus that Hynix EBITDA growth stabilizes after 2028 as supply catches up.)

https://preview.redd.it/yv8wjar4aqeh1.png?width=1845&format=png&auto=webp&s=234e06a967dcf98021976eb24c02e7c614d01ccd

DCF Scenarios

• Scenario A assumes SK Hynix will revert to it's historical EBITDA margin, which is ~40% haircut of it's current ~83% EBITDA margin from Q1.
• Scenario B assumes HBM will be a structural breakthrough of memory cyclicality, structurally elevating SK Hynix's EBITDA margin but assumes competition will reduce 15% margin in the long-term.

https://preview.redd.it/4zy8z4n8gqeh1.png?width=1959&format=png&auto=webp&s=ea50d8b5707311a07004a0282bd4a86be1accc00

Multiples Valuation

https://preview.redd.it/62n0htegfqeh1.png?width=1561&format=png&auto=webp&s=c74fa17c7732aba402b97c0af4bc75e034138bfe

Multiples suggest that the fair price per share is vastly lower than DCF's if SK Hynix earns exactly as what analysts estimates for 2026. I take it as a grain of salt because the 5Y median multiple only has 1 year (2025-26) that considers the explosive EBITDA brought by HBM and explicitly assumes 2026 is the peak of it's cycle.

Personal Takeaway

The triangulated results suggests that the fair price per share should sit at ~2,627,318. I am optimistic because all calculations are VERY conservative, debate me if I'm wrong.

(Leave a comment and I'll send you a more in-depth DCF calculation and inputs)

Revenue is on pace for roughly $51 billion in 2026. Operating margins remain among the highest in entertainment.

What Netflix could look like by 2040?

I’ve noticed several trends that seem plausible to me. Obviously, Netflix needs to focus on its business today, but these are just hypothetical scenarios based on the trends I’ve observed, indicating where I see the company heading.

A list of Netflix’s current projects.

Being done 🟢

Not being done 🔴

Cloud gaming 🟢
Console-quality titles 🟢
Mobile games 🟢
Story-driven games connected to Netflix franchises of your favorite show or movie! 🟢
Netflix House experiences. 🟢
Permanent Theme Park Partnerships 🔴
Netflix Horror Nights Stranger Things haunted house stuff etc. 🟢
Escape rooms 🔴
Live sports 🟢
Live concert streaming 🔴
Podcasts 🟢
Music 🔴
Creator content 🔴
AI-powered studio 🟢

Historical growth (2016–2025) NFLX
2016-89M subscribers
2017-111M subscribers
2018-139M subscribers
2019-167M subscribers
2020-204M subscribers
2021-222M subscribers
2022-231M subscribers
2023-260M subscribers
2024-302M subscribers
2025-325M subscribers
Average addition of roughly **24 million subscribers per year**
If Netflix continues their incredible growth like they have been in the past **Hypothetical Subscribers growth could look like this.**

2030
430M

2035
540M

2040
650M

By 2040, a larger Bull case might be close to 800 million paid memberships If we face more tailwinds with AI or another pandemic like COVID-19, we already have a significant number of households staying home more than ever, which is undoubtedly beneficial. I believe that SpaceX's potential and the global expansion of the internet will help everyone have access to entertainment, even in rural areas. Only time will tell what the future holds for Streaming and media companies i still believe Netflix has a bright future.

Any advice?